Cargando…
The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers
BACKGROUND: To identifying the effects of DNA methylation and epigenetic factors on the expression of CD133, a cancer stem cell marker, in gynecologic cancer cell lines. METHODS: Ovarian cancer cell lines (OVCAR-8 and IGROV-1) and an endometrial cancer cell line (Ishikawa) were treated with 5-aza-2`...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489563/ https://www.ncbi.nlm.nih.gov/pubmed/23067401 http://dx.doi.org/10.1186/1757-2215-5-28 |
_version_ | 1782248741844025344 |
---|---|
author | Min, Kyung-Jin So, Kyeong A Ouh, Yung-Taek Hong, Jin-Hwa Lee, Jae-Kwan |
author_facet | Min, Kyung-Jin So, Kyeong A Ouh, Yung-Taek Hong, Jin-Hwa Lee, Jae-Kwan |
author_sort | Min, Kyung-Jin |
collection | PubMed |
description | BACKGROUND: To identifying the effects of DNA methylation and epigenetic factors on the expression of CD133, a cancer stem cell marker, in gynecologic cancer cell lines. METHODS: Ovarian cancer cell lines (OVCAR-8 and IGROV-1) and an endometrial cancer cell line (Ishikawa) were treated with 5-aza-2`-deoxycytidine (DAC) or Trichostatin A (TSA). Expression of CD133 was evaluated by quantitative real-time PCR, methylation-specific PCR (MSP), reverse transcription-PCR, western blot, and FACS analysis. All results are representative of three independent experiments. RESULTS: CD133 mRNA expression varied among the different cell lines; the weakest expression was observed in OVCAR-8 cells, while it was strongly expressed in Ishikawa cells. The degree of methylation of the CD133 P2 promoter was 61% in OVCAR-8 cells, 53% in IGROV-1 cells, and 43% in Ishikawa cells. CD133 expression was increased at both the mRNA and protein level after DAC treatment. On the contrary, CD133 mRNA expression decreased after TSA treatment decreased in all cell lines except OVCAR-8. In addition, MSP of the CD133 P2 promoter revealed that methylation was reduced after treatment with either DAC or TSA. CONCLUSIONS: The expression of the CD133 antigen in primary ovarian and endometrial cancer cell lines is regulated by epigenetics, as indicated by its increased expression following DAC treatment and irregular expression pattern followed by TSA treatment. In addition, the expression of CD133 was negatively correlated with the degree of methylation of the CD133 P2 promoter. |
format | Online Article Text |
id | pubmed-3489563 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34895632012-11-06 The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers Min, Kyung-Jin So, Kyeong A Ouh, Yung-Taek Hong, Jin-Hwa Lee, Jae-Kwan J Ovarian Res Research BACKGROUND: To identifying the effects of DNA methylation and epigenetic factors on the expression of CD133, a cancer stem cell marker, in gynecologic cancer cell lines. METHODS: Ovarian cancer cell lines (OVCAR-8 and IGROV-1) and an endometrial cancer cell line (Ishikawa) were treated with 5-aza-2`-deoxycytidine (DAC) or Trichostatin A (TSA). Expression of CD133 was evaluated by quantitative real-time PCR, methylation-specific PCR (MSP), reverse transcription-PCR, western blot, and FACS analysis. All results are representative of three independent experiments. RESULTS: CD133 mRNA expression varied among the different cell lines; the weakest expression was observed in OVCAR-8 cells, while it was strongly expressed in Ishikawa cells. The degree of methylation of the CD133 P2 promoter was 61% in OVCAR-8 cells, 53% in IGROV-1 cells, and 43% in Ishikawa cells. CD133 expression was increased at both the mRNA and protein level after DAC treatment. On the contrary, CD133 mRNA expression decreased after TSA treatment decreased in all cell lines except OVCAR-8. In addition, MSP of the CD133 P2 promoter revealed that methylation was reduced after treatment with either DAC or TSA. CONCLUSIONS: The expression of the CD133 antigen in primary ovarian and endometrial cancer cell lines is regulated by epigenetics, as indicated by its increased expression following DAC treatment and irregular expression pattern followed by TSA treatment. In addition, the expression of CD133 was negatively correlated with the degree of methylation of the CD133 P2 promoter. BioMed Central 2012-10-15 /pmc/articles/PMC3489563/ /pubmed/23067401 http://dx.doi.org/10.1186/1757-2215-5-28 Text en Copyright ©2012 Min et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Min, Kyung-Jin So, Kyeong A Ouh, Yung-Taek Hong, Jin-Hwa Lee, Jae-Kwan The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers |
title | The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers |
title_full | The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers |
title_fullStr | The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers |
title_full_unstemmed | The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers |
title_short | The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers |
title_sort | effects of dna methylation and epigenetic factors on the expression of cd133 in ovarian cancers |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489563/ https://www.ncbi.nlm.nih.gov/pubmed/23067401 http://dx.doi.org/10.1186/1757-2215-5-28 |
work_keys_str_mv | AT minkyungjin theeffectsofdnamethylationandepigeneticfactorsontheexpressionofcd133inovariancancers AT sokyeonga theeffectsofdnamethylationandepigeneticfactorsontheexpressionofcd133inovariancancers AT ouhyungtaek theeffectsofdnamethylationandepigeneticfactorsontheexpressionofcd133inovariancancers AT hongjinhwa theeffectsofdnamethylationandepigeneticfactorsontheexpressionofcd133inovariancancers AT leejaekwan theeffectsofdnamethylationandepigeneticfactorsontheexpressionofcd133inovariancancers AT minkyungjin effectsofdnamethylationandepigeneticfactorsontheexpressionofcd133inovariancancers AT sokyeonga effectsofdnamethylationandepigeneticfactorsontheexpressionofcd133inovariancancers AT ouhyungtaek effectsofdnamethylationandepigeneticfactorsontheexpressionofcd133inovariancancers AT hongjinhwa effectsofdnamethylationandepigeneticfactorsontheexpressionofcd133inovariancancers AT leejaekwan effectsofdnamethylationandepigeneticfactorsontheexpressionofcd133inovariancancers |